AF Symposium has announced a series of late-breaking scientific sessions scheduled for February 2026, featuring first-in-human data and pivotal trial results across pulsed field ablation (PFA), left atrial appendage (LAA) therapies, and advanced mapping technologies.
These sessions will showcase cutting-edge clinical science presented by leading international investigators, with a strong focus on safety, durability, and long-term outcomes of next-generation atrial fibrillation therapies.
Late Breaking Clinical Science Session I
Thursday 5 February 2026, 17:00 – 19:00
- Point-by-Point “Instant” Ablation with a High-Voltage Sub-Second Pulsed Field Waveform for Atrial Fibrillation: The First-in-Human FIELD-PULSE Study – Presented by Dr Vivek Reddy
- Safety and Effectiveness of the TactiFlex Duo System: 6-Month Results of the FOCALFLEX Study – Presented by Dr John Silberbauer
- Visually-Guided Pulsed Field Ablation for Durable Pulmonary Vein Isolation: First-in-Human Acute and Chronic Remapping Results of VISION-AF – Presented by Dr Vivek Reddy
- Pulsed Field Ablation versus Standard Radiofrequency Ablation for Typical Atrial Flutter: A Sub-Study Across Phases 1 and 2 of the Pivotal ADVANTAGE AF Trial – Presented by Dr Edward Gerstenfeld
- Nanosecond Pulse Field Ablation Using a Compliant Circular Catheter to Treat Atrial Fibrillation: A Multicenter Experience – Presented by Dr Vivek Reddy
- So Happy Together – Acute and Long-Term Safety and Efficacy of Concomitant Pulsed Field Ablation of Atrial Fibrillation and Left Atrial Appendage Closure – Presented by Dr Devi Nair
- The “Blanking Period” after Pulsed Field Ablation for Persistent Atrial Fibrillation: An Implantable Monitoring Subanalysis of ADVANTAGE AF – Presented by Dr Vivek Reddy
- 12-Month Safety and Effectiveness of a Balloon-in-Basket PFA System for De Novo Pulmonary Vein Isolation in PAF and PsAF: Results from the VOLT-AF IDE Study – Presented by Dr Atul Verma
Late Breaking Clinical Science Session II
Friday 4 February 2026, 17:30 – 19:00
- Long-Term Outcomes of Pulsed Field Ablation versus Standard of Care Thermal Ablation for Paroxysmal Atrial Fibrillation: Primary Results of the ADVENT-LTO Study – Presented by Dr Vivek Reddy
- Utilization of an Artificial Intelligence Algorithm to Measure Left Atrial Appendage Dimensions – Presented by Dr Leon Ptaszek
- Early Outcomes with a Next-Generation Dual-Sealing Device for Left Atrial Appendage Closure: Results from the VERITAS Amulet 360 Pivotal Study – Presented by Dr Devi Nair
- Pulmonary Vein Isolation with a Compressible Mesh Basket Pulsed Field Ablation Catheter: First-in-Human Acute and Chronic Remapping Results of the EasyPulz Study – Presented by Dr Vivek Reddy
- Pulsed Field Ablation with a Large-Tip Focal Catheter and 3D Mapping Integration: Early Outcomes from the OMNY-AF Single-Arm Pilot Study – Presented by Dr Dinesh Sharma
- Concomitant AF Ablation and Left Atrial Appendage Elimination by Vacuum-Based Invagination and Ligation: Feasibility and Impact on LAA Electrical Activity – Presented by Dr Vivek Reddy
References
AF Symposium. 31st Annual International AF Symposium™ Scientific Program 2026. https://www.afsymposium.com/2026-program (accessed 14th January 2025)